Eli Lilly to expand US facility as demand soars for diabetes, obesity medicines
Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for.
Uncategorized
Drugs
Health
Pharma
Roche to acquire US-based Poseida Therapeutics for $1.5 billion
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Drugs
Health
Pharma
AbbVie to acquire Aliada for $1.4 billion, bags Alzheimer’s therapy
AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as.
Drugs
Health
Pharma
Merck acquires Yale University spinout Modifi Biosciences for up to $1.3 billion
Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to.
Drugs
Health
Pharma
Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion
H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.
Climate
Health
Pharma
ADNOC to buy Germany’s chemical producer Covestro for $13 billion
The Abu Dhabi National Oil Company, ADNOC, the state-owned oil company of the United Arab Emirates, will buy Germany’s chemicals maker Covestro AG.
Drugs
Health
Pharma
Roche arm to buy breast cancer portfolio from Regor for $850 million
Genentech, a member of the Roche Group, will acquire a portfolio of CDK inhibitors to treat breast cancer from Regor Pharmaceuticals for an.
Drugs
Health
Pharma
Organon & Co to buy Riovant’s arm Dermavant Sciences for $1.2 billion
US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.
Drugs
Health
Pharma
EQT Private Capital Asia to acquire controlling stake in US-based GeBBS
EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to.
Drugs
Health
Pharma
McKesson Corp., to acquire Core Ventures for $2.4 billion in cash
McKesson Corporation, the ninth-largest company by revenue in the US, will acquire Community Oncology Revitalization Enterprise Ventures, for $2.4 billion in cash to expand its.